The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Boehringer Ingelheim MENA initiated its operations in in the Middle East and North Africa over 60 years ago in Egypt; today the company’s reach spreads to sales operation in 20 countries within MENA with a regional office in Dubai. The regional office in Dubai has then expanded its regional hub responsibility to manage the Middle East, Turkey and Africa (META) region. Boehringer Ingelheim MENA is now one of the leading multinational pharmaceutical companies in the region with a team of over 800 employees. Boehringer Ingelheim is dedicated to bringing innovative health care products in human pharmaceuticals and animal health to the Middle East and North Africa (MENA) region, through presence of scientific offices in KSA, Algeria, UAE, and Egypt. Boehringer Ingelheim operates in the rest of the MENA region through partners and third party distributors.